VANDA PHARMACEUTICALS (VNDA) News Headlines

▮ More

Date

Headline

8/21/2019 7:07:44 AM Vanda Pharma Names Aranthan Jones As Chief Corporate Affairs And Communications Officer

8/19/2019 7:04:57 AM Vanda Pharma FDA Update For HETLIOZ; Receive CRL From FDA

8/19/2019 7:00:00 AM Vanda Pharmaceuticals FDA Update for HETLIOZ® in the Treatment of Jet Lag Disorder (Press Release)

8/19/2019 5:15:17 AM VNDA - Lag Or Rise? ANAB - Gallop Or Flounder? And More...

7/29/2019 7:28:28 AM Biotech Stocks Facing FDA Decision In August 2019

7/22/2019 7:05:05 AM Vanda Pharma Issues FDA Update For HETLIOZ In Treatment Of Jet Lag Disorder

7/22/2019 7:00:00 AM Vanda Pharmaceuticals FDA Update for HETLIOZ® in the Treatment of Jet Lag Disorder (Press Release)

5/1/2019 4:15:38 PM Vanda Pharma Q1 Loss/share $0.01 Vs. Profit $0.06 Year Ago

4/24/2019 4:32:11 PM Vanda Pharmaceuticals Appoints Phaedra Chrousos To Board Of Directors

4/16/2019 4:20:18 AM AXSM Has Had An Awesome Run. What Awaits These 13 Biotech Stocks In Q2, 2019?

2/13/2019 4:06:18 PM Vanda Pharmaceuticals Q4 EPS $0.19 Vs. Loss $0.04 Year Ago

12/20/2018 7:07:07 AM Vanda Pharma: FDA Accepts HETLIOZ SNDA For Review In Treatment Of Jet Lag Disorder

12/10/2018 7:05:37 AM Vanda Announces Positive Pivotal Study Results For HETLIOZ In Patients With Smith-Magenis Syndrome

12/3/2018 7:29:19 PM GBT On Fast Track, GH In Good Health, For BHVN, It's All Gain, No Pain

12/3/2018 9:47:35 AM Vanda Pharmaceuticals (VNDA) Has Spiked To A New High On Study Results

12/3/2018 6:07:08 AM Vanda Says Tradipitant Met Primary Endpoint In VLY686-2301 Phase II Clinical Study

11/8/2018 9:47:53 AM Vanda Pharmaceutical Inc. (VNDA) Has Risen To A New High After Q3 Report

11/1/2018 9:41:47 AM Vanda Gets FDA Letter Regarding Corporate Webpage

9/26/2018 9:53:19 AM Vanda Pharmaceuticals Inc. (VNDA) Is Rising After S&P Index Change

9/13/2018 3:19:01 AM ADIL On Track, PGNX Slumps On Phase III Study Failure, VNDA On Watch